Access the full text.
Sign up today, get DeepDyve free for 14 days.
Y. Ohya, Nobuhiko Ochi, Naoki Mizutani, C. Hayakawa, Kazuyoshi Watanabe (1991)
Nonketotic hyperglycinemia: treatment with NMDA antagonist and consideration of neuropathogenesis.Pediatric neurology, 7 1
(1990)
Genomic analysis of nonketotic hyperglycinaemia : a partial deletion of Pprotein gene
Kiyoshi Hayasaka, Kiyoshi Hayasaka, Keiya Tada, Keiya Tada, Noboru Fueki, Noboru Fueki, Iku Takahashi, Iku Takahashi, Akira Igarashi, Akira Igarashi, Toshifumi Takabayashi, Toshifumi Takabayashi, R. Baumgartner, R. Baumgartner (1987)
Feasibility of prenatal diagnosis of nonketotic hyperglycinemia: existence of the glycine cleavage system in placenta.The Journal of pediatrics, 110 1
D. Trauner, T. Page, C. Greco, L. Sweetman, S. Kulovich, W. Nyhan (1981)
Progressive neurodegenerative disorder in a patient with nonketotic hyperglycinemia.The Journal of pediatrics, 98 2
J. Kadonaga, K. Jones, R. Tjian (1986)
Promoter-specific activation of RNA polymerase II transcription by Sp1Trends in Biochemical Sciences, 11
T. Shinka, S. Kure, Y. Sakata, M. Takayanagi, Y. Matsubara, K. Narisawa (1998)
Assignment1 of Gldc encoding glycine decarboxylase to mouse chromosome 19C by in situ hybridization and a CA repeat polymorphism in the Gldc geneCytogenetic and Genome Research, 83
I. Gonzalez, S. Tugendreich, P. Hieter, J. Sylvester (1993)
Fixation times of retroposons in the ribosomal DNA spacer of human and other primates.Genomics, 18 1
M. Blake, Robert Jambou, Andrew Swick, Jeanne Kahn, Jane AZIZKHANl (1990)
Transcriptional initiation is controlled by upstream GC-box interactions in a TATAA-less promoterMolecular and Cellular Biology, 10
S. Kure, M. Takayanagi, K. Narisawa, K. Tada, J. Leisti (1992)
Identification of a common mutation in Finnish patients with nonketotic hyperglycinemia.The Journal of clinical investigation, 90 1
A. Kume, H. Koyata, T. Sakakibara, Y. Ishiguro, S. Kure, K. Hiraga (1991)
The glycine cleavage system. Molecular cloning of the chicken and human glycine decarboxylase cDNAs and some characteristics involved in the deduced protein structures.The Journal of biological chemistry, 266 5
S. Kure, K. Narisawa, K. Tada (1991)
Structural and expression analyses of normal and mutant mRNA encoding glycine decarboxylase: three-base deletion in mRNA causes nonketotic hyperglycinemia.Biochemical and biophysical research communications, 174 3
M. Isobe, H. Koyata, T. Sakakibara, K. Momoi-Isobe, K. Hiraga (1994)
Assignment of the true and processed genes for human glycine decarboxylase to 9p23-24 and 4q12.Biochemical and biophysical research communications, 203 3
K. Morohashi, K. Sogawa, T. Omura, Y. Fujii‐Kuriyama (1987)
Gene structure of human cytochrome P-450(SCC), cholesterol desmolase.Journal of biochemistry, 101 4
S. Kure, M. Rolland, Jaako Leisti, H. Mandel, Y. Sakata, K. Tada, Y. Matsubara, K. Narisawa (1999)
Prenatal diagnosis of non‐ketotic hyperglycinaemia: enzymatic diagnosis in 28 families and DNA diagnosis detecting prevalent Finnish and Israeli–Arab mutationsPrenatal Diagnosis, 19
S. Smale, D. Baltimore (1989)
The “initiator” as a transcription control elementCell, 57
T. Sakakibara, H. Koyata, Y. Ishiguro, S. Kure, A. Kume, K. Tada, K. Hiraga (1990)
One of the two genomic copies of the glycine decarboxylase cDNA has been deleted at a 5' region in a patient with nonketotic hyperglycinemia.Biochemical and biophysical research communications, 173 3
R. Breathnach, I. PierreChambon (1981)
Organization and expression of eucaryotic split genes coding for proteins.Annual review of biochemistry, 50
S. Kure, K. Tada, K. Narisawa (1997)
Nonketotic hyperglycinemia: Biochemical, molecular, and neurological aspectsJapanese Journal of Human Genetics, 42
T. Evans, G. Felsenfeld (1989)
The erythroid-specific transcription factor eryf1: A new finger proteinCell, 58
A. Jackson, D. Applegarth, J. Toone, S. Kure, H. Levy (1999)
Atypical Nonketotic Hyperglycinemia With Normal Cerebrospinal Fluid to Plasma Glycine RatioJournal of Child Neurology, 14
S. Kure, H. Koyata, A. Kume, Y. Ishiguro, K. Hiraga (1991)
The glycine cleavage system. The coupled expression of the glycine decarboxylase gene and the H-protein gene in the chicken.The Journal of biological chemistry, 266 5
R. Graves, P. Tontonoz, S. Ross, B. Spiegelman (1991)
Identification of a potent adipocyte-specific enhancer: involvement of an NF-1-like factor.Genes & development, 5 3
Shigeo Kure, H. Mandel, M. Rolland, Y. Sakata, T. Shinka, A. Drugan, A. Boneh, K. Tada, Y. Matsubara, K. Narisawa (1998)
A missense mutation (His42Arg) in the T-protein gene from a large Israeli-Arab kindred with nonketotic hyperglycinemiaHuman Genetics, 102
J. Dodgson, J Engel (1983)
The nucleotide sequence of the adult chicken alpha-globin genes.The Journal of biological chemistry, 258 7
Keiya Tada, K. Narisawa, Toshio Yoshida, Tasuke Konno, Yoshimasa Yokoyama, Hiroshi Nakagawa, Kaneo Tanno, Keiko Mochizuki, Tsuneo Arakawa, Tadashi Yoshida, Goro Kikuchi (1969)
Hyperglycinemia: A Defect in Glycine Cleavage ReactionTohoku Journal of Experimental Medicine, 98
Mutations in the glycine decarboxylase gene ( GLDC ) cause nonketotic hyperglycinemia (NKH), an inborn error of metabolism characterized by severe neurological disturbance. We have determined the structure of GLDC and of its pseudogene ( ψ GLDC ) and studied their expression for a molecular analysis of NKH. The GLDC gene spans at least 135 kb and consists of 25 exons. All donor and acceptor sites adhere to the canonical GT-AG rule, except for the donor site of intron 21, where a variant form GC is used instead of GT. The transcription initiation site has been assigned to a residue 163 bp upstream from the translation initiation triplet by primer extension analysis. The ψ GLDC gene has no intron and shares 97.5% homology with the coding region of functional GLDC , suggesting that ψ GLDC is a processed pseudogene that arose from the GLDC transcript about 4–8 million years ago. RNA blotting analysis has revealed that GLDC is expressed in human liver, kidney, brain, and placenta. We have also examined a patient with NKH with no detectable GLDC mRNA in his lymphoblasts. Exons 1–3 of the functional GLDC gene from this patient are not amplified by polymerase chain reaction (PCR), whereas those from control subjects are. These results suggest a large homozygous deletion (at least 30 kb) in the patient. Furthermore, we have devised a semi-quantitative PCR to estimate the number of GLDC alleles by using ψ GLDC as an internal control and have confirmed the homozygosity and heterozygosity of the deletion in the patient and his parents, respectively. Structural information of GLDC and ψ GLDC should facilitate the molecular analysis of NKH.
Human Genetics – Springer Journals
Published: Mar 1, 2000
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.